Charles River Laboratories International, Inc.
(NYSE : CRL)

( )
CRL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -3.62%130.137.5%$425.96m
EFXEquifax, Inc. -0.11%193.852.0%$215.96m
CPRTCopart, Inc. -1.79%63.092.2%$142.35m
CRLCharles River Laboratories International, Inc. 0.91%213.134.4%$140.26m
BAHBooz Allen Hamilton Holding Corp. -1.26%106.252.1%$119.17m
ICLRICON plc -1.71%196.892.7%$109.62m
FLTFLEETCOR Technologies, Inc. 0.65%186.584.0%$100.77m
RCMR1 RCM, Inc. 2.50%9.860.0%$82.98m
FOURShift4 Payments, Inc. 1.92%45.590.0%$58.37m
MEDPMedpace Holdings, Inc. 1.45%206.671.1%$56.82m
SYNHSyneos Health, Inc. -0.53%33.960.0%$55.93m
WEXWEX, Inc. 0.69%161.726.0%$55.57m
LFGArchaea Energy, Inc. 0.00%25.880.0%$49.68m
FCNFTI Consulting, Inc. 2.06%168.595.8%$45.14m
GGenpact Ltd. -1.29%44.517.2%$43.62m

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment consists of the commercial production and sale of research models, research products, and the provision of services related to the maintenance and monitoring of research models and the management of the clients’ research operations. The Discovery and Safety Assessment segment offers integrated drug discovery services directed at the identification, screening, and selection of a lead compound for drug development and offers safety assessment services, including bioanalysis, drug metabolism, pharmacokinetics, toxicology, and pathology. The Manufacturing Support segment consists of Microbial Solutions, which provides in vitro (non-animal) lot-release testing products, microbial detection products, and species identification services, Biologics Solutions, which performs specialized testing of biologics as well as contract development and manufacturing, and Avian Vaccine Services, which supplies specific-pathogen-free chicken eggs and chickens. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.